Dialysis
109
14
18
52
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
14 trials with published results (13%)
Research Maturity
52 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.4%
7 terminated out of 109 trials
88.1%
+1.6% vs benchmark
17%
19 trials in Phase 3/4
27%
14 of 52 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 52 completed trials
Clinical Trials (109)
CANagliflozin In DIALysis Patients
MRI Technical Development and Applications in Kidney Disease
Impact of Dialysis Modality
Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America
Study of the Determinants of Emergency Dialysis in Reunion Island
Feasibility of Intradialytic Monitoring During CKRT
Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
Dialysis Catheter Caps Case Feasibility Study
Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With Hyperphosphatemia
A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia
A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia
Cardio-Renal Registry
A Communication Tool to Assist Older Adults Facing Dialysis Choices
Dialysis Geriatric Care Model
Left Atrial Appendage Occlusion in Dialysis Patients With Atrial Fibrillation: A Multicentre Pilot Study
Wise Choices in the Intensive Care Unit
Protein Supplementation During Dialysis (PROSED)
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia